Treatment with the investigational therapeutic rusfertide has proven to be a potential treatment option for patients with ...

The VERIFY trial explores rusfertide to manage polycythemia vera without causing iron deficiency symptoms, Dr. Aaron Gerds explained.

Panelists discuss how risk stratification, symptom burden, and splenomegaly guide treatment decisions for a 68-year-old woman with intermediate-risk myelofibrosis who isn’t interested in transplant.

For patients with a rare type of blood cancer, treatment might finally be coming out of the Dark Ages. People with the ...

Andrew Kuykendall, MD, Moffitt Cancer Center, explains the goals of the VERIFY trial and why its data on rusfertide could have paradigm-changing implications for patients with polycythemia vera (PV) ...

Recently, to my surprise, I came down with bladder cancer. I am a healthy 66-year-old man who is 5 feet, 11 inches tall, 215 ...

Early symptoms may include painless lumps or swelling under the skin, weakness, fatigue, unintentional weight loss, and chills, though many people don’t experience symptoms in the early stages.